Metoprolol Succinate Extended-Release Tablets (25 mg) are being recalled because they failed to meet dissolution acceptance criteria during stability testing. The recall affects 27,648 100-count bottles and 5,376 500-count bottles. When a medication fails dissolution tests, it may not release the active ingredient into the body as intended, which can affect the drug's performance.
If the tablets do not dissolve properly, the medication may not reach effective levels in the bloodstream, potentially leading to inadequate treatment of the condition for which it was prescribed. No injuries or adverse events related to this issue have been reported to date.
You have 2 options:
Quantity: 27,648 100-count Bottles; 5,376 500-count Bottles
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.